Involvement of TG2 in BrCa, postulated since 1996 51, has been confirmed by many reports supporting the relevant role of the enzyme in promoting EMT, metastatic progression 16 and drug resistance 4,52. The gene discussed is TGM2; the disease is invasive breast carcinoma.